Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production

Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production

Abstract Introduction Botulinum toxin A (BoT/A) treatment failure (BTF) affects patients subjected to repeated BoT/A exposure for cosmetic indications. BoT/A’s general formulation contains core BoT/A and complexing proteins. BTF may be caused by antibody-induced treatment failure. Antibodies against...

Full description

Bibliographic Details
Main Authors: Rungsima Wanitphakdeedecha, Watsachon Kantaviro, Panittra Suphatsathienkul, Ploypailin Tantrapornpong, Chadakan Yan, Chalermkwan Apinumtham, Yuttana Srinoulprasert
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-05-01
Series:Dermatology and Therapy
Subjects:
Antibody
Botulinum toxin A
Complexing protein
ELISA
Secondary botulinum toxin A treatment failure
Online Access:https://doi.org/10.1007/s13555-020-00397-5

Internet

https://doi.org/10.1007/s13555-020-00397-5

Similar Items